ClinConnect ClinConnect Logo
Search / Trial NCT05418647

Effect of Low Versus High Dialysate Sodium Concentration During Hemodialysis on Dialysis Recovery Time

Launched by ALEXANDRIA UNIVERSITY · Jun 10, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Hemodialysis, Recovery Time, Dialysate Na

ClinConnect Summary

This clinical trial is studying how different levels of sodium in the dialysate (the fluid used during hemodialysis) affect how quickly patients recover after their dialysis sessions. Researchers want to find out if using a lower or higher amount of sodium can make a difference in recovery time for patients undergoing hemodialysis, which is a treatment for those with end-stage kidney disease.

To be eligible for this study, participants need to be at least 18 years old and have been on long-term hemodialysis three times a week for more than 90 days. They should be able to read and write and be in good mental health. Unfortunately, those who have certain medical conditions, such as severe dementia or current hospital needs, won't be able to participate. If you join the study, you can expect to provide feedback through surveys about your experiences during dialysis, helping researchers understand the best way to support recovery for patients like you.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with end-stage renal disease who have been prescribed long term hemodialysis and undergo four-hour HD treatments three times a week for more than 90 days.
  • Patient must be at least 18 years old. They must be able to read and write, as well as be in complete mental health.
  • Exclusion Criteria:
  • Inability to complete the surveys due to reading or hearing difficulties, actual instability of clinical condition that necessitate hospitalization, dementia, active malignancy or liver failure.

About Alexandria University

Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.

Locations

Alexandria, , Egypt

Alexandria, , Egypt

Patients applied

0 patients applied

Trial Officials

Mohamed Mamdouh Elsayed, MD

Principal Investigator

lecturer

osama M Refai, MBBCh

Study Chair

resident of Nephrology & Internal Medicine, Alexandria University Hospitals

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials